| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.47B | 55.65B | 55.80B | 71.53B | 57.09B | 37.03B |
| Gross Profit | 16.71B | 13.23B | 13.05B | 23.46B | 20.11B | 10.28B |
| EBITDA | 9.01B | 8.03B | 10.49B | 19.80B | 16.99B | 8.26B |
| Net Income | 4.60B | 3.47B | -24.81B | 7.60B | 6.64B | 662.49M |
Balance Sheet | ||||||
| Total Assets | 109.15B | 113.62B | 119.14B | 154.34B | 143.29B | 140.03B |
| Cash, Cash Equivalents and Short-Term Investments | 20.57B | 25.77B | 20.36B | 20.81B | 19.93B | 21.16B |
| Total Debt | 18.49B | 20.74B | 23.81B | 27.37B | 20.91B | 9.50B |
| Total Liabilities | 31.58B | 34.68B | 39.74B | 50.38B | 44.43B | 29.97B |
| Stockholders Equity | 77.57B | 78.94B | 79.40B | 103.96B | 98.86B | 102.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.63B | 7.79B | 2.01B | 5.14B | 8.23B |
| Operating Cash Flow | 0.00 | 7.52B | 12.73B | 10.85B | 9.88B | 9.56B |
| Investing Cash Flow | 0.00 | 1.48B | -5.95B | -8.66B | -19.49B | -4.18B |
| Financing Cash Flow | 0.00 | -5.87B | -8.12B | -1.60B | 8.12B | -3.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥277.44B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
73 Outperform | ¥261.07B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥475.50B | 28.49 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥368.21B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥503.87B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% | |
54 Neutral | ¥585.32B | 11.29 | 4.83% | 2.95% | -2.67% | -85.21% |